The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data
Abstract
Purpose: To identify baseline prognostic factors and assess whether pretreatment quality of life (QoL) predicts survival in patients with locally advanced or metastatic esophago-gastric cancer. Patients and Methods: Between 1992 and 2001, 1,080 patients were enrolled into three randomized, controlled trials assessing fluorouracil-based combination chemotherapy. All patients were required to complete the European Organization for Research and Treatment of Cancer core QoL questionnaire before random assignment. Results: Of the 1,080 patients randomly assigned, 979 (91%) died. Four independent poor prognostic factors were identified by multivariate analysis: performance status ≥ 2 (hazard ratio [HR], 1.58; 99% CI, 1.25 to 1.98), liver metastases (HR, 1.41; 99%CI, 1.14 to 1.74), peritoneal metastases (HR, 1.33; 99%CI, 1.01 to 1.74) and alkaline phosphatase ≥ 100 U/L (HR, 1.41; 99% CI, 1.14 to 1.76). A prognostic index was constructed dividing patients into good (no risk factor), moderate (one or two risk factors) or poor (three or four risk factors) risk groups. One-year survival for good, moderate, and poor risk groups were 48.5%, 25.7%, and 11%, respectively, and the survival differences among these groups were highly significant (P < .00001). Compared with the good risk group, the moderate risk group had nearly twice the risk of death, and the poor risk group had 3.5-fold increased risk of death. Pretreatment physical (P = .003), role functioning (P < .001), and global QoL (P < .001) predicted survival. Conclusion: Four poor prognostic factors were identified and a simple prognostic index was devised. Information from this analysis can be used to aid clinical decision-making, help individual patient risk stratification, and serve as benchmark for the planning for future phase III trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Verwaal, V. J., van Ruth, S., de Bree, E., van Slooten, G. W., van Tinteren, H., Boot, H., & Zoetmulder, F. A. N. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.187 · Cited by 2,049
Sadeghi, B., Arvieux, C., Glehen, O., Beaujard, A. C., Rivoire, M., Baulieux, J., Fontaumard, E., Brachet, A., Caillot, J. L., Faure, J. L., et al. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000115)88:2<358::aid-cncr16>3.0.co;2-o · Cited by 1,200
Self-reported weight and height
Rowland, M. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/52.6.1125 · Cited by 994
Webb, A., Cunningham, D., Scarffe, J. H., Harper, P., Norman, A., Joffe, J. K., Hughes, M., Mansi, J., Findlay, M., Hill, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.261 · Cited by 870
Self-citationGlimelius, B., Ekström, K., Hoffman, K., Graf, W., Sjödén, P.-O., Haglund, U., Svensson, C., Enander, L.-K., Linné, T., Sellsröm, H., et al. (1997) · Annals of Oncology · doi:10.1023/a:1008243606668 · Cited by 849
Andreyev, H. J. N., Norman, A. R., Oates, J., & Cunningham, D. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10090-9 · Cited by 797
Self-citationPyrhönen, S., Kuitunen, T., Nyandoto, P., & Kouri, M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.114 · Cited by 789
Vanhoefer, U., Rougier, P., Wilke, H., Ducreux, M. P., Lacave, A. J., Van Cutsem, E., Planker, M., Santos, J. G. D., Piedbois, P., Paillot, B., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2648 · Cited by 531
Ross, P., Nicolson, M., Cunningham, D., Valle, J., Seymour, M., Harper, P., Price, T., Anderson, H., Iveson, T., Hickish, T., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.105 · Cited by 475
Self-citationKöhne, C.-H., Cunningham, D., Di Costanzo, F., Glimelius, B., Blijham, G., Aranda, E., Scheithauer, W., Rougier, P., Palmer, M., Wils, J., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf034 · Cited by 464
Self-citation(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.671 · Cited by 431
Ohtsu, A., Shimada, Y., Shirao, K., Boku, N., Hyodo, I., Saito, H., Yamamichi, N., Miyata, Y., Ikeda, N., Yamamoto, S., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.130 · Cited by 427
Coates, A., Porzsolt, F., & Osoba, D. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00049-x · Cited by 327
Quality of life in lung cancer patients
Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00179-3 · Cited by 290
Waters, J. S., Norman, A., Cunningham, D., Scarffe, J. H., Webb, A., Harper, P., Joffe, J. K., Mackean, M., Mansi, J., Leahy, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690350 · Cited by 275
Self-citationPhase II Trial of Weekly Irinotecan Plus Cisplatin in Advanced Esophageal Cancer
Ilson, D. H., Saltz, L., Enzinger, P., Huang, Y., Kornblith, A., Gollub, M., O'Reilly, E., Schwartz, G., DeGroff, J., Gonzalez, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3270 · Cited by 268
Baseline quality of life predicts survival in patients with advanced colorectal cancer
Maisey, N. R., Norman, A., Watson, M., Allen, M. J., Hill, M. E., & Cunningham, D. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00098-9 · Cited by 244
Self-citationDancey, J., Zee, B., Osoba, D., Whitehead, M., Lu, F., Kaizer, L., Latreille, J., & Pater, J. L. (1997) · Quality of Life Research · doi:10.1023/a:1026442201191 · Cited by 243
Ilson, D. H., Ajani, J., Bhalla, K., Forastiere, A., Huang, Y., Patel, P., Martin, L., Donegan, J., Pazdur, R., Reed, C., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1826 · Cited by 204
Ajani, J. A., Baker, J., Pisters, P. W. T., Ho, L., Mansfield, P. F., Feig, B. W., & Charnsangavej, C. (2002) · Cancer · doi:10.1002/cncr.10279 · Cited by 160
The prognostic value of quality of life scores during treatment for oesophageal cancer
Blazeby, J. M., Brookes, S. T., & Alderson, D. (2001) · Gut · doi:10.1136/gut.49.2.227 · Cited by 149
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson, D. H., Forastiere, A. A., Arquette, M. A., Costa, F., Heelan, R. T., Huang, Y., & Kelsen, D. P. (2000) · PubMed · Cited by 135
Wislöff, F., & Hjorth, M. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.222667.x · Cited by 108
Polée, M., Hop, W. C. J., Kok, T. C., Eskens, F. A. L. M., van der Burg, M. E. L., Splinter, T. A. W., Siersema, P. D., Tilanus, H. W., Stoter, G., & van der Gaast, A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601364 · Cited by 97
Ilson, D. H., Bains, M. S., Kelsen, D. P., O'Reilly, E. M., Karpeh, M. S., Coit, D. G., Rusch, V. W., Gönen, M., Wilson, K., & Minsky, B. D. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.147 · Cited by 95
Morgan, D., Hill, G., & Burkinshaw, L. (1980) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.10.2101 · Cited by 90
Tebbutt, N. C., Norman, A., Cunningham, D., Iveson, T. J., Seymour, M., Hickish, T., Harper, P., Maisey, N. R., Mochlinski, K., Prior, Y., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf273 · Cited by 86
Self-citationTaş, F., Aykan, N. F., Aydıner, A., Uygun, K., Başaran, M., Çamlıca, H., & Topuz, E. (2000) · American Journal of Clinical Oncology · doi:10.1097/00000421-200002000-00015 · Cited by 16
Cited by
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
Cunningham, D., Starling, N., Rao, S., Iveson, T., Nicolson, M., Coxon, F., Middleton, G., Daniel, F., Oates, J., & Norman, A. R. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa073149 · Cited by 2,285
Self-citationGastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Fanta, P., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0008 · Cited by 1,684
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Chemotherapy for advanced gastric cancer
Wagner, A. D., Syn, N. L., Moehler, M., Grothe, W., Yong, W. P., Tai, B.-C., Ho, J., & Unverzagt, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004064.pub4 · Cited by 1,299
Lagergren, J., Smyth, E., Cunningham, D., & Lagergren, P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31462-9 · Cited by 1,141
Self-citation
Metadata
- Authors
- Chau, I., Norman, A. R., Cunningham, D., Waters, J. S., Oates, J., & Ross, P. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-06-15
- Volume
- 22
- Issue
- 12
- Pages
- 2395-2403
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2167112387
- Cited by
- 524
- References
- 37
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.